Company intelligence / Profile preview

Sherlock Biosciences

Cambridge/Waltham, Massachusetts, USAsherlock.bio ↗

Ownership: Private
Employees: ~60
Development stage: Preclinical

Overview

Sherlock Biosciences has developed and commercialized rapid, accurate, and affordable molecular diagnostic tests using its proprietary SHERLOCK™ and INSPECTR™ platforms. In 2020, it received the first FDA authorization for a CRISPR-based diagnostic. Its pipeline includes additional at-home and point-of-care tests targeting infectious diseases and other indications. The acquisition of Sense Biodetection expanded its manufacturing capabilities and product offerings[4][6].

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: CRISPR-based diagnosticsSynthetic biology-based diagnosticsDevice
Industry: Molecular Diagnostics

Drug pipeline

1 asset

CT/NG molecular self-test

Pre-clinical

Indications: Chlamydia trachomatis, Neisseria gonorrhoeae

Partnerships

Forsyth Institute – strategic partnership focused on R&D related to human biomarker detection in oral cavity/oral health applications

Beyond the preview

Go deeper on Sherlock Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sherlock Biosciences.

Explore the full profile